Bed Bath & Beyond ‘Spyware’ Violates Pennsylvania Wiretap Act – Class Action Complaint
Executive Summary
Visitors to BB&B’s website were not informed and did not consent to its session replay “spyware,” which tracks how consumers interact with the site, “their mouse movements and clicks, keystrokes, search terms, information inputted into the website, and pages and content viewed,” the plaintiff says.
You may also be interested in...
FDA’s Linda Katz Takes MoCRA Questions At IBA Regulatory Workshop
The director of FDA’s Office of Cosmetics and Colors addressed questions on the responsible person required by the Modernization of Cosmetics Regulations Act, safety substantiation, adverse event reporting and more at the IBA virtual event.
Cosmetics Europe Expanding To Meet Historic Challenges: ‘There’s Never Been A Time Like This’
Director-general John Chave discusses regulatory heavy-handedness in the EU, implications for animal testing, declining European investment, and Cosmetics Europe’s message to policymakers going into the 2024 EU elections and beyond.
Akili Turns Heel, Goes ‘All In’ On OTC Model For ADHD Digital Therapeutics
The Boston, MA-based company says the pivot away from Rx will enable it to pursue a significantly larger market and remove “key friction points” that have prevented patients from accessing its game-based digital ADHD treatment. The company is targeting year-over-year cost savings of $8m-$18m after investments to juice up its direct digital marketing program.